American Century Companies Inc Biogen Inc. Transaction History

American Century Companies Inc

$156 Billion
Q1 2024

A detailed history of American Century Companies Inc transactions in Biogen Inc. stock. As of the latest transaction made, American Century Companies Inc holds 842,467 shares of BIIB stock, worth $195 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

842,467

Previous 988,676 14.79%

Holding current value

$195 Million

Previous $256 Million 28.99%

% of portfolio

0.12%

Previous 0.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $31 Million - $39.1 Million	-146,209 Reduced 14.79%	842,467 $182 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $220 Million - $265 Million	988,676 New	988,676 $256 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $50.7 Million - $57.3 Million	200,310 Added 28.67%	898,928 $231 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $89.6 Million - $104 Million	325,430 Added 87.2%	698,618 $199 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $2.67 Million - $3.05 Million	-10,426 Reduced 2.72%	373,188 $104 Million

Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $23.2 Million - $28.2 Million	91,793 Added 31.46%	383,614 $106 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $26.5 Million - $36.6 Million	-136,278 Reduced 31.83%	291,821 $77.9 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $84.7 Million - $101 Million	-451,703 Reduced 51.34%	428,099 $87.3 Million
Q1 2022 May 11, 2022	BUY	$193.77 - $244.14 $4.66 Million - $5.87 Million	24,030 Added 2.81%	879,802 $185 Million
Q4 2021 Feb 07, 2022	SELL	$223.92 - $287.77 $63.4 Million - $81.5 Million	-283,047 Reduced 24.85%	855,772 $205 Million
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $29.2 Million - $38.1 Million	-103,224 Reduced 8.31%	1,138,819 $322 Million
Q2 2021 Aug 05, 2021	BUY	$259.0 - $414.71 $66.9 Million - $107 Million	258,217 Added 26.25%	1,242,043 $430 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $1.9 Million - $2.22 Million	7,804 Added 0.8%	983,826 $275 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $21.7 Million - $32.7 Million	-91,986 Reduced 8.61%	976,022 $239 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $9.36 Million - $10.8 Million	35,366 Added 3.42%	1,068,008 $303 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $64.5 Million - $85.4 Million	-249,314 Reduced 19.45%	1,032,642 $276 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $8.86 Million - $11.2 Million	-32,955 Reduced 2.51%	1,281,956 $406 Million
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $29.1 Million - $40.2 Million	-132,163 Reduced 9.13%	1,314,911 $390 Million
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $828,011 - $928,695	3,808 Added 0.26%	1,447,074 $337 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $43.9 Million - $48.4 Million	-200,148 Reduced 12.18%	1,443,266 $338 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $5.43 Million - $8.5 Million	-25,064 Reduced 1.5%	1,643,414 $0
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $44.7 Million - $56.7 Million	160,607 Added 10.65%	1,668,478 $502 Million
Q3 2018 Nov 02, 2018	BUY	$293.51 - $383.83 $108 Million - $141 Million	366,361 Added 32.09%	1,507,871 $533 Million
Q2 2018 Aug 08, 2018	SELL	$257.52 - $306.91 $7.68 Million - $9.15 Million	-29,819 Reduced 2.55%	1,141,510 $331 Million
Q1 2018 May 03, 2018	BUY	$260.13 - $367.91 $44.2 Million - $62.5 Million	169,942 Added 16.97%	1,171,329 $321 Million
Q4 2017 Feb 02, 2018	BUY	$307.64 - $344.58 $29.4 Million - $32.9 Million	95,432 Added 10.53%	1,001,387 $319 Million
Q3 2017 Nov 01, 2017	BUY	$281.15 - $329.69 $255 Million - $299 Million	905,955	905,955 $284 Million

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Biogen Inc. Transaction History